Characteristic

All respondents

Planning on or received COVID-19 vaccine

Not planning on COVID-19 vaccine

p-value

Total respondents, n (%)

52 (100)

43 (83)

9 (17)

Age, mean (SD; range)

53.4 (10.2; 33-75)

52.7 (10.5; 33-75)

56.7 (8.4; 45-72)

0.16

Gender, n (%)

0.002

    Female

28 (54)

19 (44)

9 (100)

    Male

24 (46)

24 (56)

0

Race/ethnicity, n (%)

0.005

Non-Hispanic White

43 (83)

39 (91)

4 (44)

Other

9 (17)

4 (9)

5 (56)

Education, n (%)

0.14

High school or less

6 (12)

3 (7)

3 (33)

Some college

10 (19)

8 (19)

2 (22)

College graduate

25 (48)

22 (51)

3 (33)

Graduate school

11 (21)

10 (23)

1 (11)

Cardiovascular disease, ^*n (%)

21 (40)

21 (49)

0 (0)

0.007

Diabetes, n (%)

24 (46)

23 (54)

1 (11)

0.03

Hypertension, n (%)

31 (60)

25 (58)

6 (67)

0.72

^#of health conditions, ^**mean (SD; range)

 1.48 (1.06; 0-3)

1.63 (1.07; 0-3)

0.78 (0.67; 0-2)

0.03

^#of prescription medications, mean (SD; range)

2.10 (1.49; 0-6)

2.09 (1.41; 0-6)

2.11 (1.90; 0-5)

0.84

Smoking, n (%)

0.44

Yes

3 (6)

2 (5)

1 (11)

No

49 (94)

41 (95)

8 (89)

Received influenza vaccine during 2019-2020 flu season

0.14

Yes

18 (35)

17 (40)

1 (11)

No

34 (65)

26 (60)

8 (89)

Influenza vaccination during 2020-2021 flu season, n (%)

< 0.001

Already received

17 (33)

15 (35)

2 (22)

Plan on getting

25 (48)

25 (58)

0 (0)

Not planning on getting

10 (19)

3 (7)

7 (78)

Statin nonadherence, n (%)

1

Primary

47 (90)

39 (91)

8 (89)

Secondary

5 (10)

4 (9)

1 (11)

Currently taking a statin, n (%)

0.59

Yes

7 (14)

5 (12)

2 (22)

No

45 (86)

38 (88)

7 (78)

Original recruitment method, n (%)

0.14

Online classified advertisements

26 (50)

24 (56)

2 (22)

Academic medical centers

26 (50)

19 (44)

7 (78)